Indicações para Utilização da Cintigrafia Óssea no Cancro da Mama

Authors

  • Inês Próspero Serviço de Medicina Nuclear, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal https://orcid.org/0000-0003-0668-7993
  • Gonçalo Ferreira Serviço de Medicina Nuclear, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal https://orcid.org/0000-0001-9588-7203
  • Sarah Lopes Serviço de Oncologia, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal
  • Cátia Ribeiro Serviço de Cirurgia, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal https://orcid.org/0000-0001-8563-9580

DOI:

https://doi.org/10.25748/arp.26856

Abstract

Bone scintigraphy is a useful imaging modality in breast cancer, by assessing the presence of metastasis with osteoblastic activity. Nevertheless, information on its appropriate use is sparse and the evidence supporting it is limited. The purpose of this article is to review and synthesize the current recommendations for ordering bone scintigraphy in the staging and surveillance of patients with breast cancer, as well as in monitoring metastatic disease. It aims to provide a convenient tool for clinical practice, so that bone scintigraphy use results in benefits for the patient, simultaneously with a rational consumption of health-care resources.

Published

2022-12-30

Issue

Section

Perspectives